These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 37007005)

  • 41. Biodegradable dendritic Boltorn™ nanoconstructs: A promising avenue for cancer theranostics.
    Korake S; Shaikh A; Salve R; Gajbhiye KR; Gajbhiye V; Pawar A
    Int J Pharm; 2021 Feb; 594():120177. PubMed ID: 33333177
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy.
    Mosafer J; Abnous K; Tafaghodi M; Mokhtarzadeh A; Ramezani M
    Eur J Pharm Biopharm; 2017 Apr; 113():60-74. PubMed ID: 28012991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biomimetic Targeted Theranostic Nanoparticles for Breast Cancer Treatment.
    Marshall SK; Angsantikul P; Pang Z; Nasongkla N; Hussen RSD; Thamphiwatana SD
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235009
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recent progress on nanoparticle-based drug delivery systems for cancer therapy.
    Xin Y; Yin M; Zhao L; Meng F; Luo L
    Cancer Biol Med; 2017 Aug; 14(3):228-241. PubMed ID: 28884040
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functionalized milk-protein-coated magnetic nanoparticles for MRI-monitored targeted therapy of pancreatic cancer.
    Huang J; Qian W; Wang L; Wu H; Zhou H; Wang AY; Chen H; Yang L; Mao H
    Int J Nanomedicine; 2016; 11():3087-99. PubMed ID: 27462153
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biomimetic nanoarchitecturing: A disguised attack on cancer cells.
    Jha A; Nikam AN; Kulkarni S; Mutalik SP; Pandey A; Hegde M; Rao BSS; Mutalik S
    J Control Release; 2021 Jan; 329():413-433. PubMed ID: 33301837
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gadolinium loaded nanoparticles in theranostic magnetic resonance imaging.
    Liu Y; Zhang N
    Biomaterials; 2012 Jul; 33(21):5363-75. PubMed ID: 22521487
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advances in the use of MOFs for Cancer Diagnosis and Treatment: An Overview.
    Abuçafy MP; da Silva BL; Oshiro-Junior JA; Manaia EB; Chiari-Andréo BG; Armando RAM; Frem RCG; Chiavacci LA
    Curr Pharm Des; 2020; 26(33):4174-4184. PubMed ID: 32250216
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MRI-guided liposomes for targeted tandem chemotherapy and therapeutic response prediction.
    Ren L; Chen S; Li H; Zhang Z; Zhong J; Liu M; Zhou X
    Acta Biomater; 2016 Apr; 35():260-8. PubMed ID: 26873364
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel Strategies for Disrupting Cancer-Cell Functions with Mitochondria-Targeted Antitumor Drug-Loaded Nanoformulations.
    S Allemailem K; Almatroudi A; Alsahli MA; Aljaghwani A; M El-Kady A; Rahmani AH; Khan AA
    Int J Nanomedicine; 2021; 16():3907-3936. PubMed ID: 34135584
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
    Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nanotechnology-based immunotherapies to combat cancer metastasis.
    Zhao Y; Bilal M; Qindeel M; Khan MI; Dhama K; Iqbal HMN
    Mol Biol Rep; 2021 Sep; 48(9):6563-6580. PubMed ID: 34424444
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preparation and evaluation of dabrafenib-loaded, CD47-conjugated human serum albumin-based nanoconstructs for chemoimmunomodulation.
    Pham LM; Poudel K; Phung CD; Nguyen TT; Pandit M; Nguyen HT; Chang JH; Jin SG; Jeong JH; Ku SK; Choi HG; Yong CS; Kim JO
    Colloids Surf B Biointerfaces; 2021 Dec; 208():112093. PubMed ID: 34482192
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current developments and applications of microfluidic technology toward clinical translation of nanomedicines.
    Liu D; Zhang H; Fontana F; Hirvonen JT; Santos HA
    Adv Drug Deliv Rev; 2018 Mar; 128():54-83. PubMed ID: 28801093
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hybrid protein-inorganic nanoparticles: From tumor-targeted drug delivery to cancer imaging.
    Elzoghby AO; Hemasa AL; Freag MS
    J Control Release; 2016 Dec; 243():303-322. PubMed ID: 27794493
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Radiolabeling of Theranostic Nanosystems.
    Das S; Imlimthan S; Airaksinen AJ; Sarparanta M
    Adv Exp Med Biol; 2021; 1295():49-76. PubMed ID: 33543455
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Squalene-PEG: Pyropheophorbide-a nanoconstructs for tumor theranostics.
    Adriouach S; Vorobiev V; Trefalt G; Allémann E; Lange N; Babič A
    Nanomedicine; 2019 Jan; 15(1):243-251. PubMed ID: 30304701
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical translation of gold nanoparticles.
    Zhang R; Kiessling F; Lammers T; Pallares RM
    Drug Deliv Transl Res; 2023 Feb; 13(2):378-385. PubMed ID: 36045273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IAEA Contribution to Nanosized Targeted Radiopharmaceuticals for Drug Delivery.
    Jalilian AR; Ocampo-García B; Pasanphan W; Sakr TM; Melendez-Alafort L; Grasselli M; Lugao AB; Yousefnia H; Dispenza C; Janib SM; Khan IU; Maurin M; Ulański P; Loo SCJ; Safrany A; Osso JA; Duatti A; Katti KV
    Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631646
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nano-fats for bugs: the benefits of lipid nanoparticles for antimicrobial therapy.
    Thorn CR; Thomas N; Boyd BJ; Prestidge CA
    Drug Deliv Transl Res; 2021 Aug; 11(4):1598-1624. PubMed ID: 33675007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.